| PPAR action in human placental development and pregnancy and its complications F Wieser, L Waite, C Depoix, RN Taylor PPAR research 2008 (1), 527048, 2008 | 87 | 2008 |
| Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds V Prima, C Depoix, B Masselot, P Formstecher, P Lefebvre The Journal of steroid biochemistry and molecular biology 72 (1-2), 1-12, 2000 | 66 | 2000 |
| Molecular Regulation of Human Placental Growth Factor (PlGF) Gene Expression in Placental Villi and Trophoblast Cells is Mediated via the Protein Kinase A … C Depoix, MK Tee, RN Taylor Reproductive sciences 18 (3), 219-228, 2011 | 59 | 2011 |
| Control of retinoic acid receptor heterodimerization by ligand-induced structural transitions: A novel mechanism of action for retinoid antagonists C Depoix, MH Delmotte, P Formstecher, P Lefebvre Journal of Biological Chemistry 276 (12), 9452-9459, 2001 | 51 | 2001 |
| Clinical and in vitro evidence against placenta infection at term by severe acute respiratory syndrome coronavirus 2 A Colson, CL Depoix, G Dessilly, P Baldin, O Danhaive, C Hubinont, ... The American journal of pathology 191 (9), 1610-1623, 2021 | 39 | 2021 |
| Hypoxia‐inducible factor 2 alpha impairs human cytotrophoblast syncytialization: new insights into placental dysfunction and fetal growth restriction A Colson, CL Depoix, P Baldin, C Hubinont, P Sonveaux, F Debiève The FASEB Journal 34 (11), 15222-15235, 2020 | 28 | 2020 |
| HIF1A and EPAS1 potentiate hypoxia-induced upregulation of inhibin alpha chain expression in human term cytotrophoblasts in vitro CL Depoix, I De Selliers, C Hubinont, F Debiève MHR: Basic science of reproductive medicine 23 (3), 199-209, 2017 | 26 | 2017 |
| Impaired vascular endothelial growth factor expression and secretion during in vitro differentiation of human primary term cytotrophoblasts CL Depoix, A Colson, C Hubinont, F Debieve Angiogenesis 23, 221-230, 2020 | 23 | 2020 |
| Viability of primary term cytotrophoblast cell culture in normoxia and hypoxia C Depoix, LA Barret, C Hubinont, F Debiève MHR: Basic science of reproductive medicine 19 (1), 29-34, 2012 | 21 | 2012 |
| Translin coactivates steroidogenic factor-1-stimulated transcription SH Mellon, SR Bair, C Depoix, JL Vigne, NB Hecht, PB Brake Molecular endocrinology 21 (1), 89-105, 2007 | 21 | 2007 |
| Reversible effects of oxygen partial pressure on genes associated with placental angiogenesis and differentiation in primary‐term cytotrophoblast cell culture F Debiève, C Depoix, D Gruson, C Hubinont Molecular Reproduction and Development 80 (9), 774-784, 2013 | 19 | 2013 |
| Is 8% O2 more normoxic than 21% O2 for long-term in vitro cultures of human primary term cytotrophoblasts? CL Depoix, F Haegeman, F Debiève, C Hubinont MHR: Basic science of reproductive medicine 24 (4), 211-220, 2018 | 15 | 2018 |
| Inhibin alpha gene expression in human trophoblasts is regulated by interactions between TFAP2 and cAMP signaling pathways CL Depoix, F Debiève, C Hubinont Molecular Reproduction and Development 81 (11), 1009-1018, 2014 | 12 | 2014 |
| HIF1A and EPAS1 mRNA and protein expression during in vitro culture of human primary term cytotrophoblasts and effect of oxygen tension on their expression CL Depoix, O Flabat, F Debiève, C Hubinont Reproductive Biology 16 (3), 203-211, 2016 | 11 | 2016 |
| Placental angiogenesis CL Depoix, RN Taylor Placental Bed Disorders, 1, 52-62, 2010 | 7 | 2010 |
| COVID-19 during Pregnancy: Clinical and In Vitro Evidence against Placenta Infection at Term by SARS-CoV-2. A Colson, C Depoix, G Dessilly, P Baldin, O Danhaive, C Hubinont, ... The American journal of pathology 191 (9), 1610, 2021 | 6 | 2021 |
| Effects of chemotherapy on placental development and function using in vitro culture of human primary cytotrophoblasts CL Depoix, A Colson, M Mhallem-Gziri, C Hubinont, F Debieve Investigational new drugs 38, 547-557, 2020 | 6 | 2020 |
| Isolation of primary cytotrophoblasts from human placenta at term A Colson, CL Depoix, C Hubinont, F Debiève Bio-protocol 11 (19), e4185-e4185, 2021 | 5 | 2021 |
| Repurposing the β3-adrenergic receptor agonist mirabegron in patients with structural cardiac disease: the beta3-LVH Phase 2b randomized clinical trial JL Balligand, D Brito, O Brosteanu, B Casadei, C Depoix, F Edelmann, ... JAMA cardiology 8 (11), 1031-1040, 2023 | 3 | 2023 |
| Specific HIF-2α (hypoxia-inducible factor-2) inhibitor PT2385 mitigates placental dysfunction in vitro and in a rat model of preeclampsia (RUPP) A Colson, CL Depoix, I Lambert, C Leducq, M Bedin, M De Beukelaer, ... Hypertension 80 (5), 1011-1023, 2023 | 3 | 2023 |
